Citadel Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108K Buy
95,100
+14,400
+18% +$17.7K ﹤0.01% 11935
2025
Q4
$102K Sell
80,700
-46,300
-36% -$64.4K ﹤0.01% 11632
2025
Q3
$197K Sell
127,000
-101,200
-44% -$139K ﹤0.01% 11283
2025
Q2
$301K Sell
228,200
-142,200
-38% -$194K ﹤0.01% 9817
2025
Q1
$615K Buy
370,400
+38,600
+12% +$63.6K ﹤0.01% 8021
2024
Q4
$488K Sell
331,800
-341,200
-51% -$522K ﹤0.01% 8602
2024
Q3
$1M Buy
673,000
+88,600
+15% +$131K ﹤0.01% 6861
2024
Q2
$731K Buy
584,400
+88,800
+18% +$115K ﹤0.01% 7276
2024
Q1
$595K Buy
495,600
+288,200
+139% +$288K ﹤0.01% 7992
2023
Q4
$313K Buy
207,400
+5,600
+3% +$8.1K ﹤0.01% 9081
2023
Q3
$323K Buy
201,800
+6,400
+3% +$11.7K ﹤0.01% 9027
2023
Q2
$424K Buy
195,400
+52,900
+37% +$82.8K ﹤0.01% 8302
2023
Q1
$208K Sell
142,500
-21,700
-13% -$27.9K ﹤0.01% 10114
2022
Q4
$205K Sell
164,200
-1,700
-1% -$2.68K ﹤0.01% 10090
2022
Q3
$314K Sell
165,900
-3,200
-2% -$7.57K ﹤0.01% 9472
2022
Q2
$428K Buy
169,100
+17,100
+11% +$49.9K ﹤0.01% 9005
2022
Q1
$523K Sell
152,000
-268,800
-64% -$949K ﹤0.01% 9284
2021
Q4
$2.02M Buy
420,800
+69,500
+20% +$281K ﹤0.01% 6206
2021
Q3
$1.28M Sell
351,300
-57,200
-14% -$213K ﹤0.01% 7492
2021
Q2
$1.65M Buy
408,500
+139,100
+52% +$545K ﹤0.01% 7076
2021
Q1
$1.16M Sell
269,400
-193,200
-42% -$923K ﹤0.01% 7748
2020
Q4
$1.83M Sell
462,600
-103,300
-18% -$431K ﹤0.01% 5516
2020
Q3
$2.09M Buy
565,900
+270,300
+91% +$1.14M ﹤0.01% 4632
2020
Q2
$1.01M Buy
295,600
+143,900
+95% +$322K ﹤0.01% 5812
2020
Q1
$203K Buy
151,700
+52,600
+53% +$82.4K ﹤0.01% 7988
2019
Q4
$146K Buy
99,100
+10,700
+12% +$17.9K ﹤0.01% 8379
2019
Q3
$185K Sell
88,400
-62,900
-42% -$129K ﹤0.01% 8194
2019
Q2
$369K Sell
151,300
-37,500
-20% -$81.8K ﹤0.01% 7272
2019
Q1
$493K Buy
188,800
+114,100
+153% +$345K ﹤0.01% 6808
2018
Q4
$225K Sell
74,700
-244,200
-77% -$828K ﹤0.01% 7697
2018
Q3
$1.1M Buy
318,900
+185,200
+139% +$983K ﹤0.01% 5365
2018
Q2
$628K Buy
133,700
+59,800
+81% +$227K ﹤0.01% 6000
2018
Q1
$234K Sell
73,900
-3,800
-5% -$15.3K ﹤0.01% 7105
2017
Q4
$381K Sell
77,700
-73,100
-48% -$424K ﹤0.01% 6074
2017
Q3
$1.03M Buy
150,800
+52,900
+54% +$334K ﹤0.01% 4285
2017
Q2
$644K Sell
97,900
-64,100
-40% -$449K ﹤0.01% 4760
2017
Q1
$1.3M Sell
162,000
-173,500
-52% -$1.46M ﹤0.01% 3621
2016
Q4
$3.12M Buy
335,500
+31,400
+10% +$325K ﹤0.01% 2453
2016
Q3
$3.22M Buy
304,100
+176,200
+138% +$1.75M ﹤0.01% 2428
2016
Q2
$1.2M Sell
127,900
-234,800
-65% -$2.38M ﹤0.01% 3353
2016
Q1
$3.77M Buy
362,700
+140,100
+63% +$1.28M ﹤0.01% 2031
2015
Q4
$2.24M Sell
222,600
-40,500
-15% -$406K ﹤0.01% 2620
2015
Q3
$2.21M Buy
263,100
+40,400
+18% +$535K ﹤0.01% 2810
2015
Q2
$3.58M Buy
222,700
+600
+0.3% +$9.33K ﹤0.01% 2393
2015
Q1
$3.15M Buy
222,100
+126,000
+131% +$1.64M ﹤0.01% 2529
2014
Q4
$960K Sell
96,100
-30,400
-24% -$260K ﹤0.01% 3819
2014
Q3
$1.08M Sell
126,500
-36,200
-22% -$318K ﹤0.01% 3617
2014
Q2
$1.44M Buy
162,700
+85,200
+110% +$744K ﹤0.01% 3058
2014
Q1
$722K Sell
77,500
-68,100
-47% -$597K ﹤0.01% 3840
2013
Q4
$1.23M Buy
145,600
+38,600
+36% +$390K ﹤0.01% 3018
2013
Q3
$943K Sell
107,000
-26,200
-20% -$210K ﹤0.01% 3173
2013
Q2
$946K Buy
+133,200
New +$920K ﹤0.01% 3237

Other funds holding OPK

Citadel Advisors's OPK Position: Q1 2026 in Review

Citadel Advisors reduced its Opko Health (OPK) stake by 27% in Q1 2026, selling an estimated $958K and leaving 2,079,547 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #5735.

Citadel Advisors first reported a position in OPK in Q2 2013 and has held it in 51 quarters since. The position peaked at $26.7M in Q2 2020. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Citadel Advisors held 2,079,547 shares of Opko Health worth $2.37M as of Q1 2026.
  • Citadel Advisors sold 777,886 Opko Health shares in Q1 2026, an estimated $958K.
  • Opko Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5735 holding.
  • Citadel Advisors first reported a position in Opko Health in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Opko Health position peaked at $26.7M in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.